2025 is shaping up to be a breakthrough year for digital health. Funding is flowing, FDA guidance is evolving, and enterprise buyers are increasingly ready to partner.
And yet, most digital health startups still stall after early traction. Not because demand is lacking—but because scaling requires more than a good pilot. It takes strategic clarity, credible evidence, and commercial momentum.
At Helios, we’ve spent decades helping health tech innovators bridge that gap—from first validation to sustained growth. And we’ve seen where companies break through—and where they get stuck.
We’ve found that four strategic inflection points shape the trajectory of most digital health solutions—unlocking growth when handled right, or halting momentum when overlooked.
The 4 Critical Leverage Points for Scaling Digital Health
I. Commercial Blind Spots: Bridging the Gap Between User Value and Business Value
You’ve validated your MVP and proven it can deliver value to users—great! But the next step is where the real grind begins.
Scaling commercially means navigating a web of interconnected challenges—from how stakeholders discover and evaluate your solution, to how they adopt, integrate, and derive ongoing value from it. Success depends on more than just a great product—it requires the right mix of market segmentation, positioning, pricing, and experience design that drives awareness, acquisition, onboarding, and sustained engagement. What works for one health system, payer, or provider network may fall flat in another, even within the same segment.
Founders face critical decisions early—how much to customize vs. standardize, when to invest in scalable infrastructure vs. carry technical debt, and whether to pursue recurring revenue models or take on project-based work to stay afloat. Each decision shapes not just the product, but the company’s ability to scale efficiently and sustainably.
II. Evidence Gaps: Building a Cohesive, Cross-Stakeholder Evidence Strategy
Contrary to popular belief, many DTx failures aren’t due to product inefficacy—but a failure to build the right kind of evidence, for the right stakeholders, at the right time.
Too often, evidence generation is done in silos, designed to meet only the next milestone or satisfy a single stakeholder group. This fragmented approach drives up R&D costs and delays commercial traction.
What’s needed is an integrated evidence strategy—one that anticipates and aligns the requirements of payers, providers, regulators, and patients—while making the most of limited resources and time.
III. Breaking the Pilot Trap: Designing for Scale Before the Contract
On average, it takes 6–12 months just to close a contract for a digital health pilot—before implementation, which can stretch another 3–6 months depending on solution complexity and IT bandwidth.
To break out of the pilot trap, successful companies focus on four key elements before even stepping into the sales conversation:
- Workflow Design: Have a clearly defined (not necessarily built) plan for where your solution fits into existing workflows—for patients, providers, or payers. Know the “when, where, and how” of user interaction.
- Regulatory Readiness: Ensure contracts include BAAs, data use agreements, and compliance documentation to preempt legal and liability bottlenecks.
- Technical Architecture: Design with scalability in mind. Use standardized interoperability frameworks, integration middleware, and modular features to reduce over-customization and simplify implementation.
- Success Metrics: Define clear, measurable success criteria upfront. Know what will be measured, how, when, and from where. A measurement plan from day one signals seriousness and builds trust.
IV. Product-Market Fit Fragmentation: Designing a Scalable Roadmap
Even with a strong product-market fit in one segment, scaling across markets or use cases can introduce fragmentation. Every customer type—whether a large IDN, a payer, or a pharma partner—may require different value stories, integrations, and features.
The key is not to over-customize for every opportunity but to design a portfolio roadmap that aligns strategic capabilities with high-potential market segments. Prioritize features and integrations that serve multiple use cases and build feedback loops to continuously validate your direction.
In Summary
Scaling a digital health solution isn’t just about product performance—it’s about making the right strategic, operational, and commercial choices at critical junctures. The difference between a successful scale-up and a stalled-out pilot often comes down to:
- Seeing beyond initial traction to design for long-term success.
- Building a cross-functional, cross-stakeholder growth plan.
- Investing not just in the tech—but in the infrastructure and insight to scale it.
Helios is your partner in building and scaling digital health solutions that deliver real-world impact. We work alongside founders to bridge the gap between promising pilots and sustainable growth—clarifying the path to commercialization, aligning evidence with outcomes, and accelerating traction where it matters most. Our team brings deep, hands-on experience across product, clinical, and go-to-market execution—focused on what drives adoption, not just a strategy in slides.
Too many great digital health ideas stall—not because they didn’t work, but because they didn’t scale right.
Let’s fix that—together.
Leave a Reply